Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flucloxacillin CYP Induction Study
NCT04840641Phase 1Completed
- Sponsor
- University of Southern Denmark
- Start
- Mar 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of flucloxacillin in bacterial infection, sponsored by University of Southern Denmark. Primary endpoint: Change in Area under curve (AUC) of midazolam at Day 28. Started Mar 2021; status: completed.
02
Drugs
flucloxacillin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04840641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04840641.